Drug Database
Back to search

Poland· PL-100328789

Taptiqom

A timolol, kombinationen product containing tafluprostum + timololum, registered in Poland by Santen Oy. The same ATC class is registered in 12 of our 19 countries.

ATC S01ED51

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTaptiqomATCS01ED51REGISTER NO.PL-100328789PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tafluprostum + timololumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Timolol, kombinationen is registered in 12 of 19 countries.

Countries holding a registration under ATC S01ED51 (timolol, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search timolol, kombinationen products by name

Timolol, kombinationen · ATC S01ED51

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Tafluprostum + Timololum
Manufacturer
Santen Oy
Country
Poland (PL)
ATC code
S01ED51
ATC class
Timolol, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

1 priced
  • gtin
    05909991220327
    30 poj. jednodawkowych 0,3 ml
    PLN 83.64
  • gtin
    05909991220334

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for timolol, kombinationen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check timolol, kombinationen against other medicinesHow interaction checks work

Timolol, kombinationen · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Timolol, kombinationen in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All timolol, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Taptiqom
  • Belgium · Taptiqom
  • Bulgaria · Taptiqom, Таптиком
  • Cyprus · Taptiqom
  • Czechia · Taptiqom
  • Germany · Tafluprost/Timolol, Taptiqom
  • Denmark · Tafluprost/Timolol Santen, Taptiqom
  • Estonia · Taptiqom, Taptiqom Sine
  • Spain · Taptiqom
  • Finland · Tafluprost/Timolol Santen, Taptiqom
  • France · Taptiqom
  • United Kingdom (Northern Ireland) · Taptiqom
  • Greece · Taptiqom
  • Croatia · Taptiqom
  • Hungary · Taptiqom
  • Ireland · Taptiqom
  • Iceland · Taptiqom, Taptiqom Sine
  • Italy · Loyada, Prosoptima
  • Lithuania · Taptiqom
  • Luxembourg · Taptiqom
  • Latvia · Taptiqom
  • Malta · Taptiqom
  • Netherlands · Taptiqom
  • Norway · Taptiqom, Taptiqom Sine
  • Portugal · Taptiqom
  • Romania · Taptiqom
  • Sweden · Tafluprost/Timolol Santen, Taptiqom
  • Slovenia · Taptiqom
  • Slovakia · Taptiqom

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/55eb85f0-59cb-49d7-84d8-2bce9cc66ea5
GET /v1/drugs/55eb85f0-59cb-49d7-84d8-2bce9cc66ea5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "(15 mcg + 5 mg)/ml",
  "packaging": "05909991220327 ¦ Rp ¦ 108241\n30 poj. 0,3 ml jednodawkowych\n05909991220334 ¦ Rp ¦ 108242\n90 poj. 0,3 ml jednodawkowych",
  "substance": "Tafluprostum 15 mcg + Timololum 5 mg/ml",
  "common_name": "Tafluprostum + Timololum",
  "pl_product_id": "100328789",
  "pozwolenie_nr": "22453",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about timolol, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console